Skip to main content
Premium Trial:

Request an Annual Quote

The Bottom Line: Aug 13, 2001

Premium

Earnings for the quarter ended June 30, 2001, are in and BioInform has tabulated the quarterly earnings for some leading bioinformatics companies below. All figures are in millions of US dollars. For a more complete breakdown of the companies’ quarterly earnings reports, please see GenomeWeb’s coverage at www.genomeweb.com.

File Attachments

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.